ESCAPE Hemodynamic Congestion Index (HCI) Calculator

Clinical calculation support · Verify results before clinical use

Hemodynamic pressure assessment

Enter post-treatment invasive filling pressures to calculate RAP + PCWP. Both measurements are expressed in mmHg.

RAP +PCWP
mmHg
Use the measured right atrial pressure from right-heart catheterization or pulmonary artery catheter monitoring.
mmHg
Use a reliable wedge-pressure measurement obtained under appropriate measurement conditions.
Reset calculator

About the hemodynamic congestion index

The index calculated here is the sum of right atrial pressure and pulmonary capillary wedge pressure: HCI = RAP + PCWP. The 30 mmHg threshold comes from a secondary analysis of the PAC-guided treatment arm of the ESCAPE trial and refers to post-treatment measurements during the index hospitalization.

Outcomes reported in the 2016 analysis

Post-treatment RAP + PCWP6-month mortalityDeath or rehospitalization
<30 mmHg8.7%58.7%
≥30 mmHg45.3%84.9%

These are observed event rates from the analyzed ESCAPE cohort (PAC-guided treatment arm, n=206), not personalized risk estimates. They should not be presented as an individual's predicted probability.

Important interpretation limits

  • The threshold is based on post-treatment invasive measurements in a selected hospitalized advanced heart-failure cohort; it is not a general screening tool.
  • The sum is a simple index and does not replace assessment of each pressure, clinical congestion, perfusion, renal function, treatment response, or measurement quality.
  • The 2022 publication described a separate five-variable prognostic model using a congestion-index threshold of 34 mmHg. That model is not implemented by this calculator.
  • A value at or above the threshold should prompt contextual clinical review, not automatic escalation of diuretics or another treatment.

References

Ma TS, Paniagua D, Denktas AE, et al.Usefulness of the Sum of Pulmonary Capillary Wedge Pressure and Right Atrial Pressure as a Congestion Index that Prognosticates Heart Failure Survival (from the ESCAPE Trial). Am J Cardiol. 2016;118(6):854–859. DOI: 10.1016/j.amjcard.2016.06.040; PMID: 27474338.
Paniagua D, Levine GN, Cornwell LD, et al.Decongestion Models and Metrics in Acute Heart Failure: ESCAPE Data in the Age of the Implantable Cardiac Pressure Monitor. Tex Heart Inst J. 2022;49(4):e217587. DOI: 10.14503/THIJ-21-7587; PMID: 36001949.
Binanay C, Califf RM, Hasselblad V, et al.; ESCAPE Investigators.Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness: The ESCAPE Trial. JAMA. 2005;294(13):1625–1633. DOI: 10.1001/jama.294.13.1625; PMID: 16204662.
Clinical disclaimer: This calculator performs arithmetic and displays an association-derived threshold; it is not a validated stand-alone risk calculator and does not provide an individualized mortality estimate or treatment recommendation. Interpret measurements in context, verify data quality, and use clinical judgement. The original ESCAPE trial found no significant overall outcome benefit from routine PAC-guided therapy compared with careful clinical assessment; this secondary prognostic analysis should not be interpreted as proof that PAC use or threshold-driven treatment improves outcomes.